Cargando…
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
COVID-19 vaccines were developed and approved rapidly in response to the urgency created by the pandemic. No specific regulations existed at the time they were marketed. The regulatory agencies therefore adapted them as a matter of urgency. Now that the pandemic emergency has passed, it is time to c...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342157/ https://www.ncbi.nlm.nih.gov/pubmed/37445690 http://dx.doi.org/10.3390/ijms241310514 |